MM+M editors Marc Iskowitz and Larry Dobrow interview people of note in and around the healthcare marketing world, and chat about news impacting the sector. New episodes to be released every Wednesday.
Caputo, legislative and programs counsel for Washington watchdog group Issue One, talks about “dark money” and ethics in the advertising about Medicare drug-price negotiations.
MM+M’s Larry Dobrow and Marc Iskowitz recap highlights from the MM+M Awards, including interviews with some of the winners.
GSK Consumer Healthcare’s Tamara Rogers, global chief marketing officer, explains how the work of setting the purpose for its brands took on more urgency during the pandemic.
Javier Evelyn, founder of digital allergy management startup Alerje, discusses the lack of capital for Black founders and why structural exclusion is hampering the digital health ecosystem.
Ipsen’s Paul Murasko and Impericus’ Dr. Osama Hashmi share data-based suggestions for the kind of HCP engagement the industry should move toward in the post-pandemic landscape.
Gomola and Anthony discuss their agencies’ efforts to broaden and diversify the pipeline of healthcare marketing talent.
Calcium’s Steven Michaelson talks about the art of drive and commitment — and about conquering adversity along the way.
Joe Miles of Google Cloud explains where the healthcare system made the biggest technological leaps during the pandemic.
Steve Nelson, CEO of DuPage Medical Group, explains why medicine overall is failing to support doctors’ mental health and what his organization is doing to combat burnout among its healthcare workforce.
Max Kersting, co-founder of Regimen, the first digital therapy for erectile dysfunction, talks about how the startup is vying to replace ED pills and reduce stigma around intimate health.
Amy Welsh, Agile Therapeutics VP of marketing, discusses some of the ways she’s helping hormone patch Twirla break through in the birth control market, including advertising on dating app Tinder.
Dr. Charlotte Jones-Burton, president and co-founder of Women of Color in Pharma, returns to the podcast to share findings from a poll regarding the pharma industry’s level of commitment to DE&I.
Lisa Stockman-Mauriello’s husband Bob Mauriello talks with MM+M’s Marc Iskowitz a week after Lisa received her first dose of an experimental ALS drug that may alter the course of her disease.
The unprecedented nature of the FDA’s approval of Alzheimer’s drug Aduhelm has led to more negative publicity than perhaps any other new medication. Wayne Pines, former FDA official and now president of healthcare at APCO, joins Marc Iskowitz to discuss the implications for the agency’s role in advising pharma companies.
As the short list goes live for this year’s MM+M Awards, Otsuka’s Elaine Gamble, chair of judges, debriefs with MM+M’s Marc Iskowitz about her impressions of working with some of the 80-member jury during last month’s virtual judging, as well as general trends she noticed in the entries.
Weber Shandwick’s Peter Matheson Gay and United Minds’ Tai Wingfield discuss the role organizations can play in driving progress to close health equity gaps.
As COVID-19 vaccination slows in this country, a study finds behavioral nudges may be able to encourage the hesitant to get shots. Jacob Braude, from ZS’s applied behavioral science unit, explains the findings and their commercial applications.
With the debut of the Agency 100 issue today, MM+M’s Marc Iskowitz is joined by Stephen Madden, editor-and-chief/GM, and Larry Dobrow, executive editor, to discuss the digital and print content package and what it took to get it done.
Roni Chase, VP of marketing at Lilly and an economist by training, explains why real world evidence (RWE) deserves to play a bigger role in pharma’s commercial strategy.
Juice Pharma’s Forrest King and Harrison and Star’s Mario Muredda and Paulette Robinson join Marc Iskowitz for the second of a four-part series exploring how MAHF member agencies are progressing toward diversity, equity and inclusion.